These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29045288)

  • 41. Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibition.
    Ungar L; Rodriguez F; Mahaffey KW
    Coron Artery Dis; 2016 Nov; 27(7):604-15. PubMed ID: 27398626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation.
    Greque GV; Serrano CV; Strunz CM; Soeiro A; Santos M; Pivateli F; Jacob JL; Pesaro AE; Nicolau JC; Kalil-Filho R
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):222-9. PubMed ID: 23592528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reply concerning "Colchicine in coronary artery disease: Role of anti-inflammatory medications redefined": Prime time for anti-inflammatory agents for the management of cardiovascular diseases.
    Akodad M; Fauconnier J; Lacampagne A; Roubille F
    Int J Cardiol; 2018 Mar; 254():52. PubMed ID: 29407131
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
    Duchatelle V; Kritikou EA; Tardif JC
    Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin Function as an Anti-inflammation Therapy for Depression in Patients With Coronary Artery Disease by Downregulating Interleukin-1β.
    Ma W; Shen D; Liu J; Pan J; Yu L; Shi W; Deng L; Zhu L; Yang F; Liu J; Cai W; Yang J; Luo Y; Cui H; Liu S
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):129-35. PubMed ID: 26398164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.
    Schrör K; Huber K
    Thromb Haemost; 2015 Aug; 114(3):446-8. PubMed ID: 26288949
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of low-grade inflammation on platelets in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Würtz M; Neergaard-Petersen S; Hvas AM; Kristensen SD
    Thromb Haemost; 2015 Aug; 114(3):519-29. PubMed ID: 26062929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
    Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
    J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of p38 mitogen-activated protein kinase reduces inflammation after coronary vascular injury in humans.
    Sarov-Blat L; Morgan JM; Fernandez P; James R; Fang Z; Hurle MR; Baidoo C; Willette RN; Lepore JJ; Jensen SE; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2256-63. PubMed ID: 20689074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
    Lee BJ; Lin JS; Lin YC; Lin PT
    Nutrition; 2015 Mar; 31(3):475-9. PubMed ID: 25701337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the unstable plaque in acute coronary syndromes.
    Thompson PL; Nidorf SM; Eikelboom J
    Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unmet needs in the management of atherosclerotic cardiovascular disease: Is there a role for emerging anti-inflammatory interventions?
    Lorenzatti AJ; Retzlaff BM
    Int J Cardiol; 2016 Oct; 221():581-6. PubMed ID: 27420583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Arnica comp.-Heel® on reducing cardiovascular events in patients with stable coronary disease.
    Fioranelli M; Bianchi M; Roccia MG; Di Nardo V
    Minerva Cardioangiol; 2016 Feb; 64(1):34-40. PubMed ID: 26989948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of interleukin 1β inhibition in cardiovascular disease.
    Qamar A; Rader DJ
    Curr Opin Lipidol; 2012 Dec; 23(6):548-53. PubMed ID: 23069985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is There a Role for Colchicine in Acute Coronary Syndromes?
    Nidorf SM; Verma S
    J Am Heart Assoc; 2015 Aug; 4(8):e002372. PubMed ID: 26304942
    [No Abstract]   [Full Text] [Related]  

  • 58. Atopaxar: a review of its mechanism of action and role in patients with coronary artery disease.
    Rollini F; Tello-Montoliu A; Angiolillo DJ
    Future Cardiol; 2012 Jul; 8(4):503-11. PubMed ID: 22871190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation in acute myocardial infarction: the good, the bad and the ugly.
    Matter MA; Paneni F; Libby P; Frantz S; Stähli BE; Templin C; Mengozzi A; Wang YJ; Kündig TM; Räber L; Ruschitzka F; Matter CM
    Eur Heart J; 2024 Jan; 45(2):89-103. PubMed ID: 37587550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle.
    Munoz L; Ramsay EE; Manetsch M; Ge Q; Peifer C; Laufer S; Ammit AJ
    Eur J Pharmacol; 2010 Jun; 635(1-3):212-8. PubMed ID: 20226180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.